ARCHIVES

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

This article is from The Cancer Letter archive.

Vol. 19 No. 34 | September 3, 1993

Download PDF Visit The Full Archive

Related Articles

Review Of DCCR Programs Uncovers Problems, Assigns Scores To Each

June 30, 1978

NCI Supports Development Of Reinoids for Prevention; No Magic Bullet

May 6, 1977

Supreme Court Upholds Affordable Care Act in 5-4 Decision, Narrows Medicaid Provision

June 29, 2012

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

January 29, 2010

In Brief: Cancer Claims Morris Kupchan, Who Found Promising New Antitumor Drugs In Plants

October 29, 1976

MOPP Consequences, Including Increase In cure Rate, Describe By DeVita

May 25, 1979